HFA Premium Access

Panel discussion - Heart Failure, diabetes & SGLT2 inhibition: time to change practice?

Topic: Multidisciplinary Interventions
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim

Congress Presentation

About the speaker

Professor Martin Cowie

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
112 presentations

4 more presentations in this session

The essentials for diabetes and heart failure.

Speaker: Professor M. Cowie (Cambridge, GB)


Why could patients with heart failure and T2DM benefit from SGLT2 inhibition?

Speaker: Professor S. Verma (Toronto, CA)


Real world practices and outcomes in the management of heart failure patients with T2DM.

Speaker: Professor C. Lam (Singapore, SG)


The future of SGLT2 inhibition in heart failure: managing patients without T2DM?

Speaker: Professor A. Voors (Groningen, NL)


Access the full session

Heart Failure, diabetes & SGLT2 inhibition: time to change practice?

Speakers: Professor M. Cowie, Professor M. Cowie, Professor S. Verma, Professor C. Lam, Professor A. Voors

About the event


Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb